Billionbrains Garage Ventures LtdNSE: GROWW
Open the Billionbrains Garage Ventures Ltd page
Follow Billionbrains Garage Ventures LtdFree account. Get a note when Billionbrains Garage Ventures Ltd files.
Q1 FY27 results analysis · July 15, 2026

Billionbrains Garage Ventures Ltd (GROWW) Q1 FY27 Results Analysis: PAT Jumps 94%, EBITDA Margin Expands 11.2pp

+94.3%PAT year on year, Rs. 735.04 Cr
Cofacto ResearchPublished July 15, 20262 min readPositive read
Quick summary

Billionbrains Garage Ventures Ltd's Q1 FY27 numbers came in strong, with revenue of Rs. 1,501.42 Cr (+66.00% YoY) and PAT growth of +94.30% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quick Details
Results dateJuly 15, 2026
QuarterQ1 FY 2026-2027
Revenue (Q1)Rs. 1,501.42 Cr (+66.00% YoY)
PAT (Q1)Rs. 735.04 Cr (+94.30% YoY)
EBITDA margin64.65% (+1120 bps YoY)
EPS (Q1)Rs. 1.19 (+80.30% YoY)
Market capRs. 127,849.63 Cr
CMPRs. 203.79

Quarter Snapshot

Revenue grew 66% YoY and PAT grew 94% YoY, with EBITDA margin expanding 11.2pp to 64.65%. The balance sheet was strengthened via IPO proceeds, finance costs halved, and subsidiary contribution doubled, indicating successful scaling of lending. No explicit guidance was provided, but the company's conditional margin-expansion framework was decisively met.

Key Investment Insights

Key Positives

  • Revenue grew 66% YoY to Rs.1,501.42 Cr
  • PAT grew 94.3% YoY to Rs.735.04 Cr
  • EBITDA margin expanded 11.2pp YoY to 64.65%
  • Finance costs reduced 55.5% YoY to Rs.7.31 Cr
  • Subsidiary contribution to PAT doubled to Rs.179.90 Cr, now 24.5% of consolidated PAT

Risk Factors

  • Revenue was flat QoQ (-0.3%), indicating sequential moderation after Q4 spike
  • Employee benefits expense rose 5% QoQ due to appraisal cycle
  • No explicit FY27 revenue or margin guidance provided in the filing

Ask about this

Ask Cofacto a question about this result. Answers cite filings and company data.

Companies on this page
Share on X · LinkedIn · WhatsApp

Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.